期刊文献+

替米沙坦和阿托伐他汀联用对糖尿病肾病的保护作用 被引量:3

下载PDF
导出
摘要 目的探讨替米沙坦和阿托伐他汀联合应用对糖尿病肾病的肾脏保护作用。方法将50例糖尿病肾病患者随机分为两组,所用患者均皮下注射胰岛素控制血糖,对照组每天服用替米沙坦片80mg/d,治疗组每天服用替米沙坦片80mg/d和阿托伐他汀钙片10mg/d,疗程24周。观察治疗前后尿白蛋白排出率、血肌酐、血压、总胆固醇、低密度脂蛋白、甘油三酯等指标的变化。结果两组治疗后尿白蛋白排出率、血压、总胆固醇、低密度脂蛋白、甘油三酯均有明显下降(P<0.05)。而且治疗组尿白蛋白排出率、总胆固醇、低密度脂蛋白、甘油三酯下降的程度显著大于对照组(P<0.05)。结论替米沙坦和阿托伐他汀联用比单独应用替米沙坦更能减少糖尿病肾病的尿白蛋白排出率,延缓糖尿病肾病损害的发展进程,更好的保护肾功能。
出处 《齐齐哈尔医学院学报》 2009年第22期2777-2778,共2页 Journal of Qiqihar Medical University
  • 相关文献

参考文献3

二级参考文献14

  • 1Nakamura T, Ushiyama C, Hirokwa K, et al. Effect of cerivastatin on urinary albumin excretion and plasma endothelin- 1 concentations in type2 diabetes patients with microalbuminuria and dyslipidemia. Am J Nephrol, 2001,21(6) :449 - 454.
  • 2Kim SI, Hah DC,Lee HB. Lovastatin inhibits transforming growth factor-β1 expression in diabetic rat glomeruli and cultured rat mesangial cells. J Am Soc Nephrol,2000,11(1):80-87.
  • 3Ota T, Takamura T, Ando E, et al. Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model. Diabetdogia, 2003,46 (6): 843 - 851.
  • 4Lee TM, Su SF, Tsai CH. Effect of pravastatin on proteinuria in patients with well- controlled hypertension. Hypertension, 2002,40 ( 1 ): 67 - 73.
  • 5Tesar V. Some important news in clinical nephrology in years 2003 - 2004. Vnitr Lek, 2004,50 (Suppl 1 ): 81 - 87.
  • 6Aika M, Rabikin E, Sugivama S, et al. An HMGCOA reductase inhibitor,cerivas- tatin,suppresses growth of macrophage expressing matrix metalloproteinases, and tissue factor in vivo and in vitro. Circulation, 2001,103:276 - 283.
  • 7Elisaf M, Mikhailidis DP. Statins and renal function. Angiology,2002,53(5) :493 - 502.
  • 8EpsteinM, Campese VM. Pleiotropic effects of 3 - hydroxy-3- methylglutary coenzyme a reductase inhisitors on renal funtion. Am J Kidney Dis, 2005,45 (1): 2 - 14.
  • 9Khan MA,Collins AJ,Keane WF.Diabetes in the elderly population.Ad Ren Repac Ther,2000,7:32-51.
  • 10Hostetter TH.Prevention of the development and progression of renal disease.J Am Soc Nephol,2003,14:S144-S147.

共引文献30

同被引文献25

  • 1Danesh FR, Sadeghi M, Amro N, et al. 3 - Hydroxy - 3 - methyl - g - lu- taryl Coa reduetase iuhibitors prevent high glucose - i - ndluced proliferation of neaangial cells via modulation of Rho GTPase/p2/sigrnaling pathway [ J ]. Impli- cations for di - abetie nedphropathy Proc Nat Aead Seius. 2002, 99:8301 - 8305.
  • 2Valk EJ,Bruijn JA,Bajema IM.Diabetic nephropathy in humans:pathologic diversity[J].Curr Opin Nephrol Hypertens,2011,20(3):285.
  • 3Kikkawa R,Koya D,Haneda M.Progression of diabetic nephropathy[J].Am J Kidney Dis,2003,41(3 Suppl 1):19.
  • 4Kanwar YS,Sun L,Xie P,et al.A glimpse of various pathogenetic mechanisms of diabetic nephropathy[J].Annu Rev Pathol,2011,28(6):395.
  • 5Rosario RF,Prabhakar S.Lipids and diabetic nephropathy[J].Curr Diab Rep,2006,6(6):455.
  • 6Agarwal R.Effects of statins on renal function[J].Am J Cardiol,2006,97(5):748.
  • 7Saito S,Takayama T,Honye J. Effect of lipid-lowering therapy on plaque volume and composition in patient with coronary artery disease evaluated by three dimensional intravascular ultrasound[J].The American Journal of Chinese Medicine,2002,(11):143-146.
  • 8陈俊,朱秋萍,何雄平,傅爱清.2型糖尿病肾病患者血脂检测的意义[J].现代中西医结合杂志,2008,17(10):1571-1571. 被引量:5
  • 9周耀辉,许翎,张璐,傅君舟.雷米普利与阿托伐他汀单用或联用治疗糖尿病肾病临床观察[J].中国药房,2008,19(11):850-851. 被引量:3
  • 10王英,江从海,王惠英,胡敏.血脂异常对2型糖尿病肾病的影响[J].中国热带医学,2008,8(6):981-982. 被引量:6

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部